Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com

Stock Price vs Company Growth
1d
0.3%
1w
1.7%
1m
8.4%
3m
1.2%
6m
13.2%
1y
4.5%
5y
13.7%
10y
6.7%
all
12.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,200 0.3%
1,165
1,405
Company Overview

Sales
31,229 Cr
Growth: 13.3%
Profit after Tax
5,372 Cr
Growth: 0.6%
Large Cap
1,00,112 Cr
P/E: 22.9x
Industry P/E: 29.4x
Fundamentals

Sales (Cr) ₹ 31,229
Growth 13.3%
EBITDA 26.6%
P/S 0.6x
Dividend 0.8%
P/E 22.9x
Book Value ₹ 1,942
PEG Ratio 1.7x
ROE 17.7%
P/B 0.6x
Shareholding Pattern

Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed

The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Investors (382)
Followers (33)